Chemoinformaics analysis of 11,13-Dimethyl-12-tetradecen-1-ol Acetate
| Molecular Weight | 282.468 | nRot | 12 |
| Heavy Atom Molecular Weight | 248.196 | nRig | 2 |
| Exact Molecular Weight | 282.256 | nRing | 0 |
| Solubility: LogS | -6.501 | nHRing | 0 |
| Solubility: LogP | 7.117 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 54.335 |
| nHD | 0 | BPOL | 36.713 |
| QED | 0.262 |
| Synth | 2.772 |
| Natural Product Likeliness | 1.362 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.109 |
| Pgp-sub | 0.001 |
| HIA | 0.005 |
| CACO-2 | -4.631 |
| MDCK | 0.0000157 |
| BBB | 0.381 |
| PPB | 0.987546 |
| VDSS | 3.259 |
| FU | 0.0256837 |
| CYP1A2-inh | 0.85 |
| CYP1A2-sub | 0.197 |
| CYP2c19-inh | 0.556 |
| CYP2c19-sub | 0.254 |
| CYP2c9-inh | 0.403 |
| CYP2c9-sub | 0.724 |
| CYP2d6-inh | 0.108 |
| CYP2d6-sub | 0.052 |
| CYP3a4-inh | 0.494 |
| CYP3a4-sub | 0.182 |
| CL | 3.243 |
| T12 | 0.105 |
| hERG | 0.019 |
| Ames | 0.008 |
| ROA | 0.013 |
| SkinSen | 0.937 |
| Carcinogencity | 0.049 |
| EI | 0.974 |
| Respiratory | 0.316 |
| NR-Aromatase | 0.017 |
| Antiviral | Yes |
| Prediction | 0.66254 |